Global Hereditary Angioedema Therapeutic Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 207668
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Hereditary Angioedema Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hereditary Angioedema Therapeutic size is estimated to be USD 2600.4 million in 2026 from USD 2149.1 million in 2020, with a change XX% between 2020 and 2021. The global Hereditary Angioedema Therapeutic market size is expected to grow at a CAGR of 4.9% for the next five years.

Market segmentation

Hereditary Angioedema Therapeutic market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Intravenous

Subcutaneous

Oral

Market segment by Application, can be divided into

Hospitals

Clinics

Others

Market segment by players, this report covers

BioCryst Pharma

Ionis Pharma

Pharming Group

CSL Limited

Shire

Attune Pharma

Adverum Biotechnologies

KalVista Pharma

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Hereditary Angioedema Therapeutic

1.2 Classification of Hereditary Angioedema Therapeutic by Type

1.2.1 Overview: Global Hereditary Angioedema Therapeutic Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Type in 2020

1.2.3 Intravenous

1.2.4 Subcutaneous

1.2.5 Oral

1.3 Global Hereditary Angioedema Therapeutic Market by Application

1.3.1 Overview: Global Hereditary Angioedema Therapeutic Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Hereditary Angioedema Therapeutic Market Size & Forecast

1.5 Global Hereditary Angioedema Therapeutic Market Size and Forecast by Region

1.5.1 Global Hereditary Angioedema Therapeutic Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Hereditary Angioedema Therapeutic Market Size by Region, (2016-2021)

1.5.3 North America Hereditary Angioedema Therapeutic Market Size and Prospect (2016-2026)

1.5.4 Europe Hereditary Angioedema Therapeutic Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Hereditary Angioedema Therapeutic Market Size and Prospect (2016-2026)

1.5.6 South America Hereditary Angioedema Therapeutic Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Hereditary Angioedema Therapeutic Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Hereditary Angioedema Therapeutic Market Drivers

1.6.2 Hereditary Angioedema Therapeutic Market Restraints

1.6.3 Hereditary Angioedema Therapeutic Trends Analysis

2 Company Profiles

2.1 BioCryst Pharma

2.1.1 BioCryst Pharma Details

2.1.2 BioCryst Pharma Major Business

2.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product and Solutions

2.1.4 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 BioCryst Pharma Recent Developments and Future Plans

2.2 Ionis Pharma

2.2.1 Ionis Pharma Details

2.2.2 Ionis Pharma Major Business

2.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product and Solutions

2.2.4 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Ionis Pharma Recent Developments and Future Plans

2.3 Pharming Group

2.3.1 Pharming Group Details

2.3.2 Pharming Group Major Business

2.3.3 Pharming Group Hereditary Angioedema Therapeutic Product and Solutions

2.3.4 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Pharming Group Recent Developments and Future Plans

2.4 CSL Limited

2.4.1 CSL Limited Details

2.4.2 CSL Limited Major Business

2.4.3 CSL Limited Hereditary Angioedema Therapeutic Product and Solutions

2.4.4 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 CSL Limited Recent Developments and Future Plans

2.5 Shire

2.5.1 Shire Details

2.5.2 Shire Major Business

2.5.3 Shire Hereditary Angioedema Therapeutic Product and Solutions

2.5.4 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Shire Recent Developments and Future Plans

2.6 Attune Pharma

2.6.1 Attune Pharma Details

2.6.2 Attune Pharma Major Business

2.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product and Solutions

2.6.4 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Attune Pharma Recent Developments and Future Plans

2.7 Adverum Biotechnologies

2.7.1 Adverum Biotechnologies Details

2.7.2 Adverum Biotechnologies Major Business

2.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product and Solutions

2.7.4 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Adverum Biotechnologies Recent Developments and Future Plans

2.8 KalVista Pharma

2.8.1 KalVista Pharma Details

2.8.2 KalVista Pharma Major Business

2.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product and Solutions

2.8.4 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 KalVista Pharma Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Hereditary Angioedema Therapeutic Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Hereditary Angioedema Therapeutic Players Market Share

3.2.2 Top 10 Hereditary Angioedema Therapeutic Players Market Share

3.2.3 Market Competition Trend

3.3 Hereditary Angioedema Therapeutic Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Hereditary Angioedema Therapeutic Revenue and Market Share by Type (2016-2021)

4.2 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2016-2021)

5.2 Hereditary Angioedema Therapeutic Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Hereditary Angioedema Therapeutic Revenue by Type (2016-2026)

6.2 North America Hereditary Angioedema Therapeutic Revenue by Application (2016-2026)

6.3 North America Hereditary Angioedema Therapeutic Market Size by Country

6.3.1 North America Hereditary Angioedema Therapeutic Revenue by Country (2016-2026)

6.3.2 United States Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

6.3.3 Canada Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

6.3.4 Mexico Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Hereditary Angioedema Therapeutic Revenue by Type (2016-2026)

7.2 Europe Hereditary Angioedema Therapeutic Revenue by Application (2016-2026)

7.3 Europe Hereditary Angioedema Therapeutic Market Size by Country

7.3.1 Europe Hereditary Angioedema Therapeutic Revenue by Country (2016-2026)

7.3.2 Germany Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

7.3.3 France Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

7.3.5 Russia Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

7.3.6 Italy Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Type (2016-2026)

8.2 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Application (2016-2026)

8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region

8.3.1 Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Region (2016-2026)

8.3.2 China Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8.3.3 Japan Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8.3.4 South Korea Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8.3.5 India Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

8.3.7 Australia Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Hereditary Angioedema Therapeutic Revenue by Type (2016-2026)

9.2 South America Hereditary Angioedema Therapeutic Revenue by Application (2016-2026)

9.3 South America Hereditary Angioedema Therapeutic Market Size by Country

9.3.1 South America Hereditary Angioedema Therapeutic Revenue by Country (2016-2026)

9.3.2 Brazil Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

9.3.3 Argentina Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Type (2016-2026)

10.2 Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Application (2016-2026)

10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country

10.3.1 Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Country (2016-2026)

10.3.2 Turkey Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

10.3.4 UAE Hereditary Angioedema Therapeutic Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Hereditary Angioedema Therapeutic Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Hereditary Angioedema Therapeutic Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Hereditary Angioedema Therapeutic Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Hereditary Angioedema Therapeutic Revenue (USD Million) by Region (2016-2021)

Table 5. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2021-2026)

Table 6. BioCryst Pharma Corporate Information, Head Office, and Major Competitors

Table 7. BioCryst Pharma Major Business

Table 8. BioCryst Pharma Hereditary Angioedema Therapeutic Product and Solutions

Table 9. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Ionis Pharma Corporate Information, Head Office, and Major Competitors

Table 11. Ionis Pharma Major Business

Table 12. Ionis Pharma Hereditary Angioedema Therapeutic Product and Solutions

Table 13. Ionis Pharma Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Pharming Group Corporate Information, Head Office, and Major Competitors

Table 15. Pharming Group Major Business

Table 16. Pharming Group Hereditary Angioedema Therapeutic Product and Solutions

Table 17. Pharming Group Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. CSL Limited Corporate Information, Head Office, and Major Competitors

Table 19. CSL Limited Major Business

Table 20. CSL Limited Hereditary Angioedema Therapeutic Product and Solutions

Table 21. CSL Limited Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Shire Corporate Information, Head Office, and Major Competitors

Table 23. Shire Major Business

Table 24. Shire Hereditary Angioedema Therapeutic Product and Solutions

Table 25. Shire Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Attune Pharma Corporate Information, Head Office, and Major Competitors

Table 27. Attune Pharma Major Business

Table 28. Attune Pharma Hereditary Angioedema Therapeutic Product and Solutions

Table 29. Attune Pharma Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Adverum Biotechnologies Corporate Information, Head Office, and Major Competitors

Table 31. Adverum Biotechnologies Major Business

Table 32. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product and Solutions

Table 33. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. KalVista Pharma Corporate Information, Head Office, and Major Competitors

Table 35. KalVista Pharma Major Business

Table 36. KalVista Pharma Hereditary Angioedema Therapeutic Product and Solutions

Table 37. KalVista Pharma Hereditary Angioedema Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Global Hereditary Angioedema Therapeutic Revenue (USD Million) by Players (2019-2021)

Table 39. Global Hereditary Angioedema Therapeutic Revenue Share by Players (2019-2021)

Table 40. Breakdown of Hereditary Angioedema Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 41. Hereditary Angioedema Therapeutic Players Head Office, Products and Services Provided

Table 42. Hereditary Angioedema Therapeutic Mergers & Acquisitions in the Past Five Years

Table 43. Hereditary Angioedema Therapeutic New Entrants and Expansion Plans

Table 44. Global Hereditary Angioedema Therapeutic Revenue (USD Million) by Type (2016-2021)

Table 45. Global Hereditary Angioedema Therapeutic Revenue Share by Type (2016-2021)

Table 46. Global Hereditary Angioedema Therapeutic Revenue Forecast by Type (2021-2026)

Table 47. Global Hereditary Angioedema Therapeutic Revenue by Application (2016-2021)

Table 48. Global Hereditary Angioedema Therapeutic Revenue Forecast by Application (2021-2026)

Table 49. North America Hereditary Angioedema Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 50. North America Hereditary Angioedema Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 51. North America Hereditary Angioedema Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 52. North America Hereditary Angioedema Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 53. North America Hereditary Angioedema Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 54. North America Hereditary Angioedema Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 55. Europe Hereditary Angioedema Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 56. Europe Hereditary Angioedema Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 57. Europe Hereditary Angioedema Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 58. Europe Hereditary Angioedema Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 59. Europe Hereditary Angioedema Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 60. Europe Hereditary Angioedema Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 61. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 62. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 63. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 64. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 65. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Region (2016-2021) & (USD Million)

Table 66. Asia-Pacific Hereditary Angioedema Therapeutic Revenue by Region (2021-2026) & (USD Million)

Table 67. South America Hereditary Angioedema Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 68. South America Hereditary Angioedema Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 69. South America Hereditary Angioedema Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 70. South America Hereditary Angioedema Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 71. South America Hereditary Angioedema Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 72. South America Hereditary Angioedema Therapeutic Revenue by Country (2021-2026) & (USD Million)

Table 73. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Type (2016-2021) & (USD Million)

Table 74. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Type (2021-2026) & (USD Million)

Table 75. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Application (2016-2021) & (USD Million)

Table 76. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Application (2021-2026) & (USD Million)

Table 77. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Country (2016-2021) & (USD Million)

Table 78. Middle East & Africa Hereditary Angioedema Therapeutic Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Hereditary Angioedema Therapeutic Picture

Figure 2. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type in 2020

Figure 3. Intravenous

Figure 4. Subcutaneous

Figure 5. Oral

Figure 6. Hereditary Angioedema Therapeutic Revenue Market Share by Application in 2020

Figure 7. Hospitals Picture

Figure 8. Clinics Picture

Figure 9. Others Picture

Figure 10. Global Hereditary Angioedema Therapeutic Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Hereditary Angioedema Therapeutic Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2016-2026)

Figure 13. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region in 2020

Figure 14. North America Hereditary Angioedema Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Hereditary Angioedema Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Hereditary Angioedema Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Hereditary Angioedema Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Hereditary Angioedema Therapeutic Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Hereditary Angioedema Therapeutic Market Drivers

Figure 20. Hereditary Angioedema Therapeutic Market Restraints

Figure 21. Hereditary Angioedema Therapeutic Market Trends

Figure 22. BioCryst Pharma Recent Developments and Future Plans

Figure 23. Ionis Pharma Recent Developments and Future Plans

Figure 24. Pharming Group Recent Developments and Future Plans

Figure 25. CSL Limited Recent Developments and Future Plans

Figure 26. Shire Recent Developments and Future Plans

Figure 27. Attune Pharma Recent Developments and Future Plans

Figure 28. Adverum Biotechnologies Recent Developments and Future Plans

Figure 29. KalVista Pharma Recent Developments and Future Plans

Figure 30. Global Hereditary Angioedema Therapeutic Revenue Share by Players in 2020

Figure 31. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 32. Global Top 3 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2020

Figure 33. Global Top 10 Players Hereditary Angioedema Therapeutic Revenue Market Share in 2020

Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 35. Global Hereditary Angioedema Therapeutic Revenue Share by Type in 2020

Figure 36. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2021-2026)

Figure 37. Global Hereditary Angioedema Therapeutic Revenue Share by Application in 2020

Figure 38. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2021-2026)

Figure 39. North America Hereditary Angioedema Therapeutic Sales Market Share by Type (2016-2026)

Figure 40. North America Hereditary Angioedema Therapeutic Sales Market Share by Application (2016-2026)

Figure 41. North America Hereditary Angioedema Therapeutic Revenue Market Share by Country (2016-2026)

Figure 42. United States Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Hereditary Angioedema Therapeutic Sales Market Share by Type (2016-2026)

Figure 46. Europe Hereditary Angioedema Therapeutic Sales Market Share by Application (2016-2026)

Figure 47. Europe Hereditary Angioedema Therapeutic Revenue Market Share by Country (2016-2026)

Figure 48. Germany Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Hereditary Angioedema Therapeutic Sales Market Share by Type (2016-2026)

Figure 54. Asia-Pacific Hereditary Angioedema Therapeutic Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Hereditary Angioedema Therapeutic Revenue Market Share by Region (2016-2026)

Figure 56. China Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. South Korea Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Hereditary Angioedema Therapeutic Sales Market Share by Type (2016-2026)

Figure 63. South America Hereditary Angioedema Therapeutic Sales Market Share by Application (2016-2026)

Figure 64. South America Hereditary Angioedema Therapeutic Revenue Market Share by Country (2016-2026)

Figure 65. Brazil Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Argentina Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Type (2016-2026)

Figure 68. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Application (2016-2026)

Figure 69. Middle East and Africa Hereditary Angioedema Therapeutic Revenue Market Share by Country (2016-2026)

Figure 70. Turkey Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Saudi Arabia Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. UAE Hereditary Angioedema Therapeutic Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Methodology

Figure 74. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz